Charles River Laboratories International (CRL) Other Non-Current Assets (2009 - 2025)
Charles River Laboratories International (CRL) posted quarterly Other Non-Current Assets of $293.2 million for Q4 2025, up 5.37% year-over-year from $278.2 million in Q4 2024, and up 0.79% quarter-over-quarter from $290.9 million in Q3 2025.
Charles River Laboratories International (CRL) Other Non-Current Assets (2009 - 2025) Analysis & Trends
Charles River Laboratories International's Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $293.2 million for Q4 2025.
- In Q4 2025, Other Non-Current Assets rose 5.37% year-over-year to $293.2 million; the TTM figure through Dec 2025 stood at $293.2 million (up 5.37% YoY), while the FY2025 annual figure was $293.2 million, up 5.37% from the prior year.
- Other Non-Current Assets for Q4 2025 stood at $293.2 million, up from $290.9 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $435.6 million in Q2 2022, with the low at $148.3 million in Q4 2022.
- The 5-year median for Other Non-Current Assets is $298.8 million (2024), against an average of $285.4 million.
- Peak annual rise in Other Non-Current Assets reached 108.65% in 2023, while the deepest fall reached 64.31% in 2023.
- Charles River Laboratories International's Other Non-Current Assets stood at $151.5 million in 2021, then fell by 2.15% to $148.3 million in 2022, then soared by 108.65% to $309.4 million in 2023, then retreated by 10.07% to $278.2 million in 2024, then advanced by 5.37% to $293.2 million in 2025.
- Business Quant data shows CRL's Other Non-Current Assets at $293.2 million in Q4 2025, $290.9 million in Q3 2025, and $296.5 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 5.62 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 4.39 Bn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 567.73 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 1.18 Bn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 558.00 Mn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | 51.00 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 576.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 448.88 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 277.00 Mn |
| 10 | Charles River Laboratories International | 12.85 Bn | 12.64 Bn | 1.81 Bn | 293.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | 293.19 Mn |
| Sep 27, 2025 | 290.89 Mn |
| Jun 28, 2025 | 296.46 Mn |
| Mar 29, 2025 | 294.10 Mn |
| Dec 28, 2024 | 278.23 Mn |
| Sep 28, 2024 | 307.01 Mn |
| Jun 29, 2024 | 301.18 Mn |
| Mar 30, 2024 | 303.15 Mn |
| Dec 30, 2023 | 309.38 Mn |
| Sep 30, 2023 | 154.88 Mn |
| Jul 1, 2023 | 155.47 Mn |
| Apr 1, 2023 | 153.99 Mn |
| Dec 31, 2022 | 148.28 Mn |
| Sep 24, 2022 | 429.69 Mn |
| Jun 25, 2022 | 435.64 Mn |
| Mar 26, 2022 | 356.65 Mn |
| Dec 25, 2021 | 151.54 Mn |
| Sep 25, 2021 | 341.45 Mn |
| Jun 26, 2021 | 357.79 Mn |
| Mar 27, 2021 | 349.43 Mn |